-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Autolus Therapeutics plc quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from 2016 to 2023.
- Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.94M, a 10% increase year-over-year.
- Autolus Therapeutics plc Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $11.4M.
- Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2023 was $11.3M, a 6.36% decline from 2022.
- Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2022 was $12M, a 20.9% increase from 2021.
- Autolus Therapeutics plc annual Share-based Payment Arrangement, Expense for 2021 was $9.94M, a 50.4% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Growth (%)